The third International Stroke Trial (IST-3)

Abstract

The IST-3 trial is a large-scale randomised controlled trial of intravenous thrombolytic therapy of the drug Alteplase for patients with acute ischaemic stroke. The dataset includes a number of files describing the IST-3 dataset. The documentation files may be freely downloaded. The patient-level data are under embargo until the 25th of January 2021. To apply to the study investigators for access to the raw patient-level data before that time, please click on the file (“datashare_aug2015.sas7bdat” or “ist3.dat”) and follow the instructions. Further information about the study is available at www.ist3.com. *** The IST3 has an international trials registry ID number, which enables all the trials outputs to be linked: ISRCTN25765518 https://doi.org/10.1186/ISRCTN25765518